7月底,传奇生物通过官网低调更新高管团队信息,完成了研发体系的核心人事调整,全程未发布港交所或纳斯达克专项公告。 该公司核心人事变动如下,原全球研发总裁方国伟的名字已从官网高管名录中移除,其全部职责由邱玉红博士临时接掌,最新头衔为“临时研发负责人兼注册事务高级副总裁”。 资料显示,邱玉红并非传统研发线出身,她拥有武汉大学生物化学学士、贝勒医学院博士及博士后学历,曾在强生任职8年、诺华肿瘤任职...
Source Link7月底,传奇生物通过官网低调更新高管团队信息,完成了研发体系的核心人事调整,全程未发布港交所或纳斯达克专项公告。 该公司核心人事变动如下,原全球研发总裁方国伟的名字已从官网高管名录中移除,其全部职责由邱玉红博士临时接掌,最新头衔为“临时研发负责人兼注册事务高级副总裁”。 资料显示,邱玉红并非传统研发线出身,她拥有武汉大学生物化学学士、贝勒医学院博士及博士后学历,曾在强生任职8年、诺华肿瘤任职...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.